Cian Healthcare Sets Record Date for Capital Restructuring, Approves Fresh Equity Issuance
Cian Healthcare Limited's Implementation Committee has set January 16, 2026 as the record date for equity capital reduction and approved fresh equity issuance worth ₹23.75 crores to new promoters. The committee also appointed four new interim board directors and approved preferential allotment of 2.38 crore shares, giving new promoters 95% shareholding in the restructured company.
*this image is generated using AI for illustrative purposes only.
Cian Healthcare Limited's Resolution Plan Implementation Committee has made significant corporate restructuring decisions following the National Company Law Tribunal's approval of its resolution plan. The committee meeting held on January 09, 2026, addressed key aspects of the company's capital restructuring and board reconstitution under the Insolvency and Bankruptcy Code framework.
Record Date Declaration
The Implementation Committee has declared January 16, 2026 as the record date for the reduction, cancellation, and extinguishment of existing paid-up equity share capital held by erstwhile promoters and existing public shareholders. This step forms a crucial part of the resolution plan implementation process approved by the NCLT on December 18, 2025.
Board Reconstitution
The committee approved the appointment of four new directors to form the interim board of directors:
| Position: | Name | Designation |
|---|---|---|
| Director 1: | Mr. Pradeep Kumar Jain | Promoter and Non-Executive Director |
| Director 2: | Mr. Rajesh Jain | Promoter and Non-Executive Director |
| Director 3: | Mr. Manish Goswami | Independent Non-Executive Director |
| Director 4: | Mr. Anjani Misra | Independent Non-Executive Director |
The interim board's powers will remain suspended during the Resolution Plan Implementation Period, with all board powers being exercised by the Implementation Committee until the Resolution Plan Closure Date.
Fresh Equity Issuance
The committee approved the issuance of 2,37,50,000 fresh equity shares on a preferential basis to new promoters. Each share carries a face value of ₹10.00, bringing the total issuance value to ₹23,75,00,000.
Shareholding Distribution
| Promoter: | Equity Shares | Shareholding (%) |
|---|---|---|
| Ananta Medicare Limited: | 1,37,50,000 | 55.00% |
| Mr. Rajesh Jain: | 52,50,000 | 21.00% |
| Mr. Pradeep Kumar Jain: | 47,50,000 | 19.00% |
| Total: | 2,37,50,000 | 95.00% |
The fresh equity shares will rank pari-passu with existing equity shares in all respects. Following this preferential allotment, the company's total issued, subscribed, and paid-up equity share capital will comprise 2,50,00,000 equity shares with a face value of ₹10.00 each, aggregating to ₹25,00,00,000.
Regulatory Compliance
All decisions were made in compliance with Regulation 30 of the SEBI Listing Regulations, relevant SEBI circulars, provisions of the Insolvency and Bankruptcy Code, and the NCLT order dated December 18, 2025. The company has committed to keeping stakeholders and regulatory authorities informed of further material developments in the resolution plan implementation process.
The Implementation Committee meeting commenced at 3:00 PM IST and concluded at 3:46 PM IST on January 09, 2026, conducted through video-conferencing under the chairmanship of Roshen Chordiya, the erstwhile Resolution Professional.
Historical Stock Returns for Cian Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.00% | +10.29% | +67.76% | +159.24% | +159.24% | +159.24% |
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
